Press releaseGlobe Newswire
Scilex Holding
SCLX · NASDAQ
$2.53−$0.13 (−4.89%)TodayMarket closed ·
Prev close $2.66
Latest news
- News
Scilex Portfolio Company Semnur Pharmaceuticals Receives $100M Investment From iHolding In 10M Newly Issued Shares At $10 Per Share
- Press releaseGlobe Newswire
Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026
- NewsAkanksha Bakshi
What's Going on With Scilex Holding Stock Monday?
- News
Scilex To Sell ~6.67M Newly Issued Shares To iHolding Group at $15 Per Share For $100M In Gross Proceeds
- Press releaseGlobe Newswire
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
- Press releasePRNewswire
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
- NewsTanya Rawat
Scilex (SCLX) Stock Jumps After Dream Bowl Meme Coin Listing Update: Why Is It Moving?
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseGlobe Newswire
Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens to List on Biconomy Exchange as Early as June 23, 2026
- Press releaseGlobe Newswire
Scilex Holding Company ("Scilex") Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
- Press releaseGlobe Newswire
Scilex Holding Company ("Scilex") Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
- Press releaseGlobe Newswire
Scilex Holding Company ("Scilex") Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026
- News
European Medicines Agency Announces Meeting highlights From The Committee For Medicinal Products for Human Use, May 18-21
- Press releaseBusiness Wire
Wellgistics Health and Datavault AI to Form DelivMeds AI via PharmacyChain™ License Expansion and Acquisitions of QOLPOM Biometric Health Data and Drone Logistics IP and Majority of Tollo Health
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseBusiness Wire
Datavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum Platform
- Press releaseACCESS Newswire
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
Datavault AI Converts $13.3 Million in Convertible Debt, Strengthens Balance Sheet
- Press releaseBusiness Wire
Datavault AI Announces Closing of Initial Tranche Investment from Scilex Holding Company
- NewsErica Kollmann
Datavault And New Era Energy: AI Penny Stock Powerhouses
- Press releaseBusiness Wire
Datavault AI Secures $150 Million Strategic Investment from Scilex Holding Company to Build Supercomputer and Launch Independent Data Exchanges in the US
- News
Scilex To Exchange $200M In Semnur Stock For $200M In Bitcoin Under Securities Purchase Agreement With Institutional Investor
- Press releaseGlobe Newswire
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
Scilex Announces ZTlido Shows 51.9% Decrease In Opioid Use Compared To 45.5% With 5% Lidocaine Patch; 21.3% Achieve 20% Opioid Reduction Vs. 13.4% With Lidocaine; Non-Significant Opioid Use Change With ZTlido Vs. Significant Increase With 5% Patch
- Press releaseGlobe Newswire
Scilex Holding Company Announces Pain Medicine News Published Retrospective Claims Data on ZTlido® vs. Lidocaine 5% Patch
- NewsPiero Cingari
US Small Business Optimism Hits 3-Year High As Election Results 'Signal A Major Shift'
- Press releaseGlobe Newswire
Scilex Holding Company Enters into a Binding Term Sheet for a Joint Venture with IPMC and Bio Open Innovation Consortium to Develop and Commercialize a Phase 2 Clinical Stage, Potential Best-In-Class Novel Oral Tablet for the Treatment of Obesity and Neurodegenerative Diseases Including Alzheimer's Disease
- NewsVandana Singh
Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate
- Press releasePRNewswire
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
- NewsAvi Kapoor
Top 3 Health Care Stocks That Could Blast Off In September
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.